mrd by mass spectrometry in the peripheral blood in myeloma
Published 3 years ago • 178 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
5:26
mrd by mass spectrometry in pb and ngs in bm in patients with multiple myeloma treated with dara-krd
-
2:48
mrd status by mass spectrometry with easym predicts outcomes following autosct in multiple myeloma
-
1:24
gem2014main: assessing mrd with ngf in bone marrow and ms in peripheral blood in multiple myeloma
-
1:05
clonotypic mass spectrometry with easym assay for mrd detection in multiple myeloma
-
2:40
advantages & uses of mass spectrometry in the diagnosis and monitoring of multiple myeloma
-
4:22
mass spectrometry and response monitoring in multiple myeloma
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
4:02
the diagnostic and prognostic value of mass spectrometry in multiple myeloma
-
5:28
what is the role of imaging in mrd testing?
-
5:44
can mrd testing be done on a blood sample?
-
7:42
what is mrd?
-
1:20
mrd in myeloma
-
4:03
proteomics in myeloma: mass spectrometry and novel approaches
-
1:37
mrd in myeloma
-
2:17
mrd: a promising biomarker in multiple myeloma
-
3:02
technical tips for reliable mrd assessment in patients with multiple myeloma
-
2:05
using mrd negativity to measure depth of response & to discontinue treatment in multiple myeloma
-
1:07
mrd-guided treatment in multiple myeloma
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
8:42
assessing mrd in multiple myeloma
-
2:00
advancing mrd monitoring in myeloma
-
1:30
mrd: an important topic in myeloma therapy